{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T08:41:56Z","timestamp":1792485716505,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,9,25]],"date-time":"2027-09-25T00:00:00Z","timestamp":1821830400000},"content-version":"am","delay-in-days":267,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30EY002520"],"award-info":[{"award-number":["P30EY002520"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R24EY028764"],"award-info":[{"award-number":["R24EY028764"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R44EY027665"],"award-info":[{"award-number":["R44EY027665"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21EY035421"],"award-info":[{"award-number":["R21EY035421"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY036417"],"award-info":[{"award-number":["R01EY036417"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY037242"],"award-info":[{"award-number":["R01EY037242"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001209","name":"Knights Templar Eye Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001209","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["unrestricted institutional grants"],"award-info":[{"award-number":["unrestricted institutional grants"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["Stein Innovation Award"],"award-info":[{"award-number":["Stein Innovation Award"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroscience Methods"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.jneumeth.2026.110911","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:36:35Z","timestamp":1790177795000},"page":"110911","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A method to quantify ligand-neuron binding in vivo"],"prefix":"10.1016","volume":"437","author":[{"given":"Avinash","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Frankfort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9566-8764","authenticated-orcid":false,"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneumeth.2026.110911_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2025.1536452","article-title":"The role of neurotrophic factors in retinal ganglion cell resiliency","volume":"19","author":"Abraham","year":"2025","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jneumeth.2026.110911_bib2","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adw0218","article-title":"Cell-extrinsic controls over neocortical neuron fate and diversity","volume":"11","author":"Baumann","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jneumeth.2026.110911_bib3","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.3390\/ijms21072262","article-title":"Neuroprotective strategies for retinal ganglion cell degeneration: current status and challenges ahead","volume":"21","author":"Boia","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneumeth.2026.110911_bib4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/jmr.983","article-title":"Efficient identification of tubby-binding proteins by an improved system of T7 phage display","volume":"23","author":"Caberoy","year":"2010","journal-title":"J. Mol. Recognit."},{"key":"10.1016\/j.jneumeth.2026.110911_bib5","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1523\/JNEUROSCI.22-10-03977.2002","article-title":"TrkB gene transfer protects retinal ganglion cells from axotomy-induced death in vivo","volume":"22","author":"Cheng","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneumeth.2026.110911_bib6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00018-021-04111-2","article-title":"Secretogranin III stringently regulates pathological but not physiological angiogenesis in oxygen-induced retinopathy","volume":"79","author":"Dai","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jneumeth.2026.110911_bib7","series-title":"Glaucoma, in: StatPearls","article-title":"Treasure Island (FL)","author":"Dietze","year":"2022"},{"key":"10.1016\/j.jneumeth.2026.110911_bib8","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.3390\/ijms24043866","article-title":"Neurotrophic factors as regenerative therapy for neurodegenerative diseases: current status, challenges and future perspectives","volume":"24","author":"El Ouaamari","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneumeth.2026.110911_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/medsci14010015","article-title":"Current state of the neurotrophin-based pharmaceutics in the treatment of neurodegenerative diseases and neuroinflammation","volume":"14","author":"Fedotcheva","year":"2025","journal-title":"Med. Sci."},{"key":"10.1016\/j.jneumeth.2026.110911_bib10","doi-asserted-by":"crossref","first-page":"875","DOI":"10.4103\/1673-5374.184448","article-title":"The intricacies of neurotrophic factor therapy for retinal ganglion cell rescue in glaucoma: a case for gene therapy","volume":"11","author":"Foldvari","year":"2016","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.jneumeth.2026.110911_bib11","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.ajpath.2012.12.032","article-title":"VEGF-A is necessary and sufficient for retinal neuroprotection in models of experimental glaucoma","volume":"182","author":"Foxton","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneumeth.2026.110911_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-68488-z","article-title":"VEGF is an autocrine\/paracrine neuroprotective factor for injured retinal ganglion neurons","volume":"10","author":"Froger","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneumeth.2026.110911_bib13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000514441","article-title":"Neuroprotective factors of the retina and their role in promoting survival of retinal ganglion cells: a review","volume":"64","author":"Fudalej","year":"2021","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.jneumeth.2026.110911_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104540","article-title":"Brain-derived neurotrophic factor (BDNF) and TrkB hippocampal gene expression are putative predictors of neuritic plaque and neurofibrillary tangle pathology","volume":"132","author":"Ginsberg","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneumeth.2026.110911_bib15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.preteyeres.2014.06.003","article-title":"Functional architecture of the retina: development and disease","volume":"42","author":"Hoon","year":"2014","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jneumeth.2026.110911_bib16","doi-asserted-by":"crossref","first-page":"9507","DOI":"10.3390\/ijms25179507","article-title":"Optimal humanized Scg3-neutralizing antibodies for anti-angiogenic therapy of diabetic retinopathy","volume":"25","author":"Huang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneumeth.2026.110911_bib17","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101085RR","article-title":"Selectively targeting disease-restricted secretogranin III to alleviate choroidal neovascularization","volume":"36","author":"Ji","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.jneumeth.2026.110911_bib18","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1111\/febs.16356","article-title":"Comparative ligandomics implicates secretogranin III as a disease-restricted angiogenic factor in laser-induced choroidal neovascularization","volume":"289","author":"Ji","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.jneumeth.2026.110911_bib19","doi-asserted-by":"crossref","first-page":"10531","DOI":"10.3390\/ijms241310531","article-title":"Secretogranin III selectively promotes vascular leakage in the deep vascular plexus of diabetic retinopathy","volume":"24","author":"Ji","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneumeth.2026.110911_bib20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/02713683.2019.1663385","article-title":"Neuroprotection in glaucoma: towards clinical trials and precision medicine","volume":"45","author":"Khatib","year":"2020","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jneumeth.2026.110911_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd2590","article-title":"Receptor-ligand supplementation via a self-cleaving 2A peptide-based gene therapy promotes CNS axonal transport with functional recovery","volume":"7","author":"Khatib","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jneumeth.2026.110911_bib22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1167\/tvst.9.6.20","article-title":"Intraocular distribution and kinetics of intravitreally injected antibodies and nanoparticles in rabbit eyes","volume":"9","author":"Kim","year":"2020","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.jneumeth.2026.110911_bib23","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3390\/brainsci15070727","article-title":"Retinal neurochemistry","volume":"15","author":"Lam","year":"2025","journal-title":"Brain Sci."},{"key":"10.1016\/j.jneumeth.2026.110911_bib24","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1084\/jem.20161802","article-title":"Secretogranin III as a disease-associated ligand for antiangiogenic therapy of diabetic retinopathy","volume":"214","author":"LeBlanc","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneumeth.2026.110911_bib25","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.drudis.2018.01.013","article-title":"Ligandomics: a paradigm shift in biological drug discovery","volume":"23","author":"Li","year":"2018","journal-title":"Drug. Discov. Today"},{"key":"10.1016\/j.jneumeth.2026.110911_bib26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.31083\/j.fbl2706169","article-title":"Harnessing the neuroprotective behaviors of m\u00fcller glia for retinal repair","volume":"27","author":"Pe\u00f1a","year":"2022","journal-title":"Front. Biosci. (Landmark Ed."},{"key":"10.1016\/j.jneumeth.2026.110911_bib27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.addr.2017.09.007","article-title":"vitro and ex vivo models to study drug delivery barriers in the posterior segment of the eye","volume":"126","author":"Peynshaert","year":"2018","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.jneumeth.2026.110911_bib28","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1146\/annurev-cellbio-111315-125008","article-title":"Structural perspectives on axon guidance","volume":"32","author":"Seiradake","year":"2016","journal-title":"Annu. Rev. Cell. Dev. Biol."},{"key":"10.1016\/j.jneumeth.2026.110911_bib29","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1046\/j.0953-816X.2000.01326.x","article-title":"Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor","volume":"12","author":"Sondell","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.jneumeth.2026.110911_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1238453","article-title":"Neurotrophic factors in the physiology of motor neurons and their role in the pathobiology and therapeutic approach to amyotrophic lateral sclerosis","volume":"16","author":"Stansberry","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jneumeth.2026.110911_bib31","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.3390\/ijms25021120","article-title":"The healthy and diseased retina seen through neuron-glia interactions","volume":"25","author":"Tempone","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneumeth.2026.110911_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150321","article-title":"A method for rapid and reliable quantification of VEGF-cell binding activity","volume":"727","author":"Waduge","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jneumeth.2026.110911_bib33","article-title":"Profiling disease-selective drug targets: from proteomics to ligandomics","volume":"28","author":"Waduge","year":"2022","journal-title":"Drug. Discov. Today"},{"key":"10.1016\/j.jneumeth.2026.110911_bib34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3390\/biom15010145","article-title":"Feasibility of ex vivo ligandomics","volume":"15","author":"Waduge","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.jneumeth.2026.110911_bib35","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.3390\/ijms21176262","article-title":"Neuroprotection of retinal ganglion cells with AAV2-BDNF pretreatment restoring normal TrkB receptor protein levels in glaucoma","volume":"21","author":"W\u00f3jcik-Gryciuk","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneumeth.2026.110911_bib36","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neuron.2011.05.028","article-title":"Leptin action on GABAergic neurons prevents obesity and reduces inhibitory tone to POMC neurons","volume":"71","author":"Vong","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.jneumeth.2026.110911_bib37","doi-asserted-by":"crossref","first-page":"16326","DOI":"10.1038\/s41598-020-73353-0","article-title":"Progressive optic atrophy in a retinal ganglion cell-specific mouse model of complex I deficiency","volume":"10","author":"Wang","year":"2020","journal-title":"Sci Rep"}],"container-title":["Journal of Neuroscience Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165027026002414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165027026002414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T08:30:21Z","timestamp":1792485021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165027026002414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":37,"alternative-id":["S0165027026002414"],"URL":"https:\/\/doi.org\/10.1016\/j.jneumeth.2026.110911","relation":{},"ISSN":["0165-0270"],"issn-type":[{"value":"0165-0270","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A method to quantify ligand-neuron binding in vivo","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroscience Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneumeth.2026.110911","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110911"}}